| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2135937 | Hematology/Oncology and Stem Cell Therapy | 2012 | 6 Pages |
Abstract
The study clearly demonstrated that docetaxel is active in the treatment of endometrial cancer. Toxicity was manageable and predominantly hematologic.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rasha Hamdy Hamed, Seham Elsayed Abdelkhalek,